ADVAIR HFA INHALER SALMETEROL-FLUTICASONE

Description

Asthma (Reversible Obstructive Airway Disease).

SERETIDE EVOHALER is indicated for the regular treatment of asthma (Reversible Obstructive Airway Disease).

This can include:

• Patients under effective maintenance treatment with doses of long-acting beta agonists and inhaled corticosteroids.

• Patients who are symptomatic under current treatment with an inhaled corticosteroid.

• Patients under treatment with a regular bronchodilator who require inhaled corticosteroids.

Chronic Obstructive Pulmonary Disease (COPD): SERETIDE EVOHALER is indicated for the regular treatment of chronic obstructive pulmonary disease (COPD), such as chronic bronchitis and emphysema, and has been shown to reduce the mortality rate from all causes.